NUR 600 Topic 8 management plan defense example

Advanced Integrative Concepts: Pathophysiology, Pharmacology and Assessment Grand Canyon University Free custom sample in 24 to 48h

This NUR 600 Topic 8 sample paper defends a six-element plan for Mrs. G., an older adult living with heart failure with preserved ejection fraction, new atrial fibrillation, chronic kidney disease and diabetes. It was prepared for GCU NUR 600, Advanced Integrative Concepts: Pathophysiology, Pharmacology and Assessment, catalog code NUR-600, offered to MSN students at Grand Canyon University. Each element states what it interrupts and what success would look like: a loop diuretic, an SGLT2 inhibitor after Anker and colleagues, a beta blocker, apixaban justified by exclusion after Granger and colleagues, daily weights and supervised exercise after Kitzman and colleagues. Monitoring targets failure modes, omissions are explained and a condition for being wrong is set.

CourseNUR 600 Advanced Integrative Concepts: Pathophysiology, Pharmacology and Assessment
TopicTopic 8
Paper typeIntegrated treatment plan
LengthAbout 950 words, 3 pages
FormatAPA 7 student paper
SchoolGrand Canyon University (GCU)
ProgramMSN
UpdatedOctober 2026

Free sample paper for NUR 600 Topic 8

1

Each Element, What It Interrupts and What Success Would Look Like: Defending the Plan for an Older Adult Living With HFpEF

[Author Name]

College of Nursing and Health Care Professions, Grand Canyon University

NUR-600: Advanced Integrative Concepts: Pathophysiology, Pharmacology and Assessment

Topic 8 Assignment

[Instructor Name]

September 24, 2029

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

What this page is doingThe title states the plan's format: every element carries one line on what it is meant to interrupt and one on what a reader would see if it worked. Two elements are not drugs, one is justified by exclusion, monitoring is aimed at specific failure modes, and the plan names the condition under which it is wrong. The patient is a composite.
2

Each Element, What It Interrupts and What Success Would Look Like: Defending the Plan for an Older Adult Living With HFpEF

The Patient and the Plan's Reader

Mrs. G.'s problem list now reads: stiff-ventricle heart failure, newly found atrial fibrillation, chronic kidney disease, type 2 diabetes, hypertension and obesity. This plan is written for a skeptical reader, such as a cardiologist reviewing it or a colleague covering her care, and each element is short so it can be checked quickly.

Element 1: Loop Diuretic

Interrupts: the sodium and water retention that raises her filling pressures and venous congestion. If it works: weight falls toward her dry weight of about 91 kilograms, edema and orthopnea improve, and jugular venous pressure falls. The dose is expected to be reduced once congestion clears and the second natriuretic drug takes effect.

Element 2: Sodium-Glucose Cotransporter 2 Inhibitor

Interrupts: proximal tubular sodium reabsorption and the progression of heart failure and kidney disease. If it works: fewer episodes of decompensation and hospitalization over months, a stable kidney function after an expected early dip, and support for glucose control. This element rests on trial evidence of fewer heart failure hospitalizations in patients with preserved ejection fraction (Anker et al., 2021).

Element 3: Beta-Blocker for Rate Control

Interrupts: the rapid ventricular response of atrial fibrillation, which shortens filling time for a stiff ventricle. If it works: resting heart rate below about 110 and falling, less breathlessness on exertion, no new dizziness.

Element 4: Apixaban, Justified by Exclusion

Interrupts: clot formation in the fibrillating left atrium and the resulting risk of stroke. If it works: no stroke or systemic embolism, and no major bleeding. This element is on the list partly because of what the examination removed: had the examination or echocardiogram found moderate or severe mitral stenosis, a direct oral anticoagulant would not be appropriate and warfarin would have been required; the exclusion of valvular disease is what permits a drug that, in its main trial, produced fewer serious bleeds than warfarin (Granger et al., 2011). Her dose is set against her age, weight and creatinine, and her anemia is being investigated before or alongside its start.

What this page is doingEvery element states what it interrupts and what a reader would see if it worked. The highlighted passage shows one element justified by exclusion, naming the examination finding whose absence made the choice possible.
3

Element 5, Not a Drug: Daily Weights and a Written Action Plan

Interrupts: the delay between fluid reaccumulating and anyone noticing, which is how decompensation becomes hospitalization. If it works: she weighs herself each morning after voiding, records it, and calls the clinic if the scale climbs more than 1 kilogram overnight or 2 kilograms over seven days, so diuretic adjustments happen at home rather than in an emergency department. This element is defended as carefully as the drugs because none of them can respond to a weight gain she does not report.

Element 6, Not a Drug: Supervised Exercise and Weight Loss

Interrupts: the deconditioning and obesity that limit her exercise capacity independently of her heart. If it works: she can walk to the mailbox and back without stopping, and her weight falls gradually. When older people carrying excess weight and HFpEF were randomized to aerobic training, to caloric restriction or to both, each arm raised peak oxygen consumption, and combining them did more than either one alone (Kitzman et al., 2016). The plan refers her to cardiac rehabilitation and to a dietitian, with the diet adjusted for her kidney disease and diabetes.

Monitoring Aimed at Failure Modes

Monitoring is aimed at specific ways the plan could fail, not at a generic set of values. Overdiuresis and kidney decline: creatinine, potassium and orthostatic blood pressure at one and two weeks, with the accepted creatinine rise written into her chart. Bleeding on apixaban: hemoglobin at four weeks, with iron studies, and questions about dark stools at each visit. Bradycardia or hypotension from the beta-blocker: heart rate and blood pressure at each titration. Hypoglycemia masked by the beta-blocker: her glucose log reviewed at two weeks. Genital infection or ketoacidosis with the cotransporter inhibitor: taught signs and sick-day rules.

What Was Left Out, and Why

Several elements a reader might expect are absent on purpose. A mineralocorticoid receptor antagonist is left out because her kidney function and potassium make it unsafe for her now, not because it lacks a role in her condition; it can be reconsidered if her potassium falls. Digoxin is left out for rate control because her reduced kidney function raises its toxicity risk and a beta-blocker is expected to be enough. Rhythm control, with an antiarrhythmic drug or ablation, is deferred rather than rejected: it becomes a question if her symptoms persist once her rate is controlled and congestion has cleared. A statin is continued from her existing regimen for her diabetes and cardiovascular risk but is not presented as part of her heart failure treatment. Naming what is left out lets a reviewer challenge the omissions as easily as the inclusions, and shows that each absence was a decision rather than something forgotten. It also gives the next clinician a list of the options that remain open if the current plan falls short.

The Condition for Being Wrong

The plan rests on the working diagnosis and on the assumption that her symptoms are driven by congestion and rapid rate. It is wrong if, at eight weeks, her congestion has cleared, her rate is controlled and her breathlessness has not improved. That result would mean something else limits her, perhaps pulmonary disease not shown on spirometry, pulmonary hypertension from another cause, coronary disease or severe deconditioning, and she would be referred for exercise testing and cardiology review rather than given more of the same medicines (Heidenreich et al., 2022). A plan built from three sciences at once cannot claim certainty; it can say what would show it was mistaken, and look for it.

References

Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Bohm, M., Brunner-La Rocca, H.-P., Choi, D.-J., Chopra, V., Chuquiure-Valenzuela, E., Giannetti, N., Gomez-Mesa, J. E., Janssens, S., Januzzi, J. L., Gonzalez-Juanatey, J. R., Merkely, B., Nicholls, S. J., Perrone, S. V., Pina, I. L., ... Packer, M. (2021). Empagliflozin in heart failure with a preserved ejection fraction. New England Journal of Medicine, 385(16), 1451-1461. https://doi.org/10.1056/NEJMoa2107038

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., Bahit, M. C., Diaz, R., Easton, J. D., Ezekowitz, J. A., Flaker, G., Garcia, D., Geraldes, M., Gersh, B. J., Golitsyn, S., ... Wallentin, L. (2011). Apixaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 365(11), 981-992. https://doi.org/10.1056/NEJMoa1107039

Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., Fang, J. C., Fedson, S. E., Fonarow, G. C., Hayek, S. S., Hernandez, A. F., Khazanie, P., Kittleson, M. M., Lee, C. S., Link, M. S., ... Yancy, C. W. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145(18), e895-e1032. https://doi.org/10.1161/CIR.0000000000001063

Kitzman, D. W., Brubaker, P., Morgan, T., Haykowsky, M., Hundley, G., Kraus, W. E., Eggebeen, J., & Nicklas, B. J. (2016). Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: A randomized clinical trial. JAMA, 315(1), 36-46. https://doi.org/10.1001/jama.2015.17346

The NUR-600 Topic 8 assignment instructions

Topic 8 in NUR-600 asks students to defend a comprehensive treatment plan. Strong plans state for each element what it interrupts in the disease process and what success would look like, rather than citing a guideline as the only justification. Students should include non-drug elements, such as daily weights and exercise, defend some choices by exclusion, aim monitoring at the specific ways the plan could fail and explain why expected elements were left out. The plan should end with the condition under which it would be wrong, since a plan that cannot be wrong cannot be tested, and each element should cite the trial or guideline behind it.

How this NUR 600 Topic 8 example is built

The finished plan is written for a skeptical reader and its paragraphs are short. Each element carries one line saying what it is meant to interrupt and one line saying what a reader would see if it worked. Not every element is pharmacologic, and the two that are not are defended as carefully as the rest, since a plan built only from agents has usually stopped at the drug reference. One element is justified by exclusion: it is on the list because the examination removed the alternative that would otherwise have been preferred, and the paper says so. Monitoring is attached to failure modes rather than to routine. The last page names the result that would show the plan was wrong and what would replace it, with the follow up interval argued from how fast the process moves.

Reading the NUR 600 Topic 8 rubric

Faculty reward each element defended by what it interrupts. An Excellent plan states for the loop diuretic, SGLT2 inhibitor, beta blocker and apixaban what each interrupts and what success looks like, with Anker and colleagues and Granger and colleagues. Credit goes to non-drug elements, daily weights and supervised exercise after Kitzman and colleagues. The rubric values monitoring aimed at overdiuresis and bleeding rather than generic values. Strong plans explain leaving out a mineralocorticoid antagonist. Top marks go to a stated condition for being wrong at eight weeks.

NUR 600 Topic 8 help: mistakes that cost marks

A plan defended by guideline citation alone loses marks here, because the course spent eight topics arguing that the mechanism decides and a citation names a population instead. A second failure is an element with no step attached, recognizable when a reader cannot say what the plan is trying to interrupt. Plans that ignore the obvious alternative leave the strongest objection unanswered, and faculty read that as avoidance. Marks also go for monitoring copied as a schedule, since a measurement not aimed at a failure mode detects nothing in particular. Plans consisting only of agents have skipped the parts of management that are not prescribed. A plan with no condition for being wrong claims a certainty three sciences never deliver together.

Get an NUR-600 Topic 8 example written to your instructions

Send the NUR-600 Topic 8 assignment instructions and the rubric your classroom posts, with the case and any plan template your section requires. We write a custom example to those criteria, with every element tied to the step it interrupts, the obvious alternative refused and an abandonment condition stated, in 24 to 48 hours. The first one is free.

More NUR 600 papers and MSN samples

NUR 600 Topic 8 questions, answered

Why is a guideline citation not enough at this level?

A guideline describes what is reasonable across a population, while the paper concerns one person whose process has already been established above. Citing it answers whether the plan is defensible in general. The assignment asks something narrower: why this element, for this mechanism, in someone with these findings and these exclusions.

What does it mean to defend a choice by exclusion?

It means saying what the examination removed. An option that would ordinarily have been preferred is off the table because a finding, or the absence of one, ruled it out, and naming that makes the remaining choice look reasoned rather than arbitrary. It is also the clearest evidence that the examination earlier in the paper did any work.

Are these examples ever a substitute for clinical judgment?

No. Everything here is academic work built on composite, de-identified patients, written to show how an argument is assembled and graded. It is not direction for anybody's care, and no page of it should be read that way. Decisions about real people belong to the licensed clinicians who have the whole record and the person in front of them.

Where can I find a free NUR 600 Topic 8 sample paper?

The treatment plan for NUR 600 Topic 8 covers the patient and the reader, six elements with what each interrupts, monitoring aimed at failure modes, what was left out and the condition for being wrong. Share your NUR 600 Topic 8 prompt for a free plan.

Why is a guideline citation not enough in NUR 600 Topic 8?

A guideline says what is generally recommended; the plan must also explain why each element fits this patient and what it is expected to change.